Status:
UNKNOWN
HFpEF and 2-year Mortality of COPD Patients
Lead Sponsor:
University Hospital Olomouc
Conditions:
Chronic Obstructive Pulmonary Disease
Heart Failure
Eligibility:
All Genders
40-80 years
Brief Summary
This study was designed to assess potential relationship between heart failure with preserved ejection fraction and 2- year mortality of patients with chronic obstructive pulmonary disease
Eligibility Criteria
Inclusion
- Exacerbation of chronic obstructive pulmonary disease requiring hospitalization
- Age 40 - 80 years
- Performance status 0-1 according to Eastern Cooperative Oncology Group (ECOG)
- Long acting beta agonist (LABA)/ long acting antimuscarinic (LAMA) bronchodilator treatment
Exclusion
- Presence of major heart valve dysfunction
- Documented noncompliance with treatment
- Presence of active malignancy
- Body mass index \> 40
- Interstitial lung disease
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04277429
Start Date
July 1 2020
End Date
April 1 2025
Last Update
November 2 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Frydek Mistek Hospital
Frýdek-Místek, Czechia
2
University Hospital Olomou
Olomouc, Czechia, 77900